secwatch.observer — SEC 8-K summary
======================================

Issuer:     LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
CIK:        0001335105
Form:       8-K
Filed at:   2024-12-20T23:59:59+00:00
Accession:  0001493152-24-051050
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Lixte Biotechnology announces annual meeting results; all director nominees elected
--------------------------------------------------------------------------------

- All five director nominees (Forman, Yen, Brown, Bernards, van der Baan) elected with >653K votes for each.
- Ratification of Weinberg & Company as auditor passed with 1.33M votes for, 56K against.
- Advisory approval of executive compensation passed with 672K for, 40K against.
- Broker non-votes totaled ~670K on director and compensation proposals; none on auditor ratification.
- Annual meeting held December 19, 2024; no other business items reported.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224051050/0001493152-24-051050-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1335105/000149315224051050/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-051050

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer